ABT

Which Abbott Is the One to Own Post-Split?

Both offer good prospects, but if you can choose just one, AbbVie -- which is the device and diagnostics side -- looks a tad more promising than the pharma arm. More

Abbott: Quality Dividend Aristocrat for Long Term Dividends

Abbott Laboratories engages in the development, manufacture, and sale of health care products worldwide with a 40-year history of dividend increases More

From the Experts: 4 Stocks to Hold Forever

Forever may be a long time, but these stocks picked by our InvestorPlace experts are tried-and-true investments that you can count on for the long haul. More

7 Dividend Stock Purchases with Retirement in Mind

I am an investor in the accumulation phase. I plan on being financially independent in a few years and here are 7 dividend stocks where I added to my holdings More

Here’s Why Johnson & Johnson is Undervalued

The share price of Johnson & Johnson looks to be overvalued until you dive into the numbers and look for one-time special items that hide true earnings value More

Abbott Labs Worth Less Than Its Spinoff

Abbott Laboratories' spun-off drug business, AbbVie, is being valued at just more than $55 billion -- a few billion dollars more than ABT. More

3 Dividend Stocks in the ‘Sweet Spot’

Fiscal cliff or not, income-producing stocks will remain key -- and your best bet is to find solid, fairly valued companies that can keep hiking payouts. More